|
|
 |
|
Viewing report
|
|
|
|
Cancer Drug Delivery: Managing Cancer Patients Beyond Oral Formulation
Datamonitor, Oct 2001
Oral and injectable formulations are the two main drug delivery systems used for anti-cancer drug. However, each system is hampered by problems of its own and there is yet no answer to the problem of delivering drug with convenience and increased efficacy. The high level of interest in drug delivery technology development will, to a certain extent, close the gap in unmet need, yet it will be several years before any breakthrough is made in improving anti-cancer drug administration. This brief provides an overview the current role of drug delivery technology in the cancer market, looking at the current systems and products incorporating these technologies. This is followed by detailed analyses of these drug delivery markets in terms of their strengths and weaknesses, opportunities and threats. Finally, the future of drug delivery and its implications for the cancer therapeutic market will be examined in details.
Customers who bought this item also bought
Drug Delivery in Cancer - Technologies, Markets and Companies
Treatment Algorithms: Cancer Pain - Physician Awareness and Novel Drug Delivery Will Drive Market Opportunities
Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development
Immunotherapy in Oncology: Gaining Momentum
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
Triple Progress Analysis - Melanoma, Colorectal & Lung Cancer
Cancer Drug Discoveries: What the Future Holds
New Concepts in Cancer Therapeutics
|
|
|
|
